02/21/2026
â¤â¤RSO Testimonial On Prostate Cancerâ¤â¤
68-Year-Old Liverpool
Man with Stage 4 Prostate Cancer Metastatic to Lungs and Spine â PSA Drops from 79 to 0.32 in Just 4 Months
We continue to receive an incredible number of prostate cancer recovery stories, and each one is a reminder of what is possible when we combine powerful, science-backed protocols with determination and hope. đ
⸝
STORY:
This is the story of a 68-year-old man from Liverpool who was diagnosed with Stage 4 Prostate Cancer that had already spread (metastasized) to both his lungs and spine. His condition was considered advanced and, by conventional medical standards, very difficult to treat with any expectation of long-term survival.
In early February 2025, he began a targeted protocol through the supervision of Dr William Makis Md Phd , which included:
â˘90days intense RS0 0il Prot0col â ** mg/day
This compound was carefully dosed and monitored as part of a broader supportive program. Each plays a role:
⢠RS0 0il â to support the immune system, manage infl@mmation, cancer and tumor, and improve overall well-being.
⸝
Results After 4 Months:
By June 2025, his PSA levels had dropped from a dangerously high 79 to an astonishing 0.32. This type of dramatic improvement is rarely seen in late-stage metastatic prostate cancer using conventional treatments alone.
Even more encouraging, his energy levels improved, pain decreased, and his lung function tests showed better oxygen exchange. His spine pain reduced enough that he could resume light walking exercises daily.
About Our telehealth Clinic:
I run the largest Naturophatic Oncological Service in Both General and alternative treatment, and time and again, our patients achieve better results. This is not just about numbers on a chart â our patients:
⢠Do better clinically (with improved symptoms and daily functioning)
⢠Have better lab results
⢠Enjoy better long-term outcomes compared to standard oncology expectations
This is yet another inspiring reminder that hope is never lost, and that even in late-stage cancer, remarkable turnarounds are possible.
For educational purposes